News Update

CBIC revises tariff value of edible oils, gold & silverFormer IPS officer Sanjiv Bhatt jailed for 20 yrs for planting drugs to frame lawyerCentre receives Rs 18.5 lakh crore tax revenue upto Feb monthUN says Households waste across world is now at least one billion meals a dayExpert Committee on developing GIFT IFSC as 'Global Finance and Accounting Hub' submits report to IFSCAIndia, China hold fresh dialogue for complete disengagement on Western borders: MEADefence Production issues notification for re-organisation of DGQAThakur says India is prepared for 2036 OlympicsCBDT substitutes Form in ITR-5EV Revolution: Lessons for India to learn from US and China!London court green-signals auction of luxury apartment of fugitive Nirav ModiGovt consults RBI; finalises borrowing plan for first half of FY 2024-25Gadkari says Farmers’ protest is politically-motivatedVP calls upon women entrepreneurs to be 'Vocal for Local'America offers USD 10 mn bounty for information on ‘Blackcat’ hackers after UnitedHealth gets hitI-T- The order of the ITSC can only be reopened in cases of fraud or misrepresentation: HC8 persons including Hezbollah militants killed in Israeli strike on LebanonMacron pillories EU-South Africa trade deal; calls it ‘really bad’ in BrazilThailand’s Lower House okays Bill to legitimise same-sex marriageYellen warns China against clean energy dumpingMilky Way’s central black hole - Twisted magnetic field observedCus - Assessee has not proved beyond reasonable doubt that goods in question imported under air way bills/bills of entry were in fact filed by him and hence the only natural corollary available to Revenue is confiscation of same: CESTATSmall investors help Trump Media’s valuation skyrocket to USD 13 billionJustice Ritu Raj Awasthi joins as Judicial member of Lokpal
 
Medical Device Manufacturing - Over 700 Cr investments committed - PLI benefits approved

By TIOL News Service

NEW DELHI, FEB 12, 2021: THE Medical Device Sector in India suffers from a considerable cost of manufacturing disability vis-à-vis competing economies, inter alia, on account of lack of adequate infrastructure, domestic supply chain and logistics, high cost of finance, inadequate availability of power, limited design capabilities, low focus on research and development (R&D) and skill development.

With an objective to boost domestic manufacturing, attract large investment in Medical Device Sector, the Department of Pharmaceuticals had launched a Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Medical Devices to ensure a level playing field for the domestic manufacturers of medical devices with a total financial outlay of Rs.3,420 crore for the period 2020-21 to 2027-28.

The applications under four different Target Segments including “Cancer care/Radiotherapy Medical Devices”, “Radiology & Imaging Medical Devices (both ionizing & non-ionizing radiation products) and Nuclear Imaging Devices”, "Anaesthetics & Cardio-Respiratory Medical Devices including Catheters of Cardio-Respiratory Category & Renal Care Medical Devices” and “All Implants including Implantable Electronic Devices” were invited.

The Government has approved applications of following applicants, which fulfill the prescribed laid down criteria, as under:

Sl.No.

Name of approved Applicant

Name of Eligible Product

Committed Investment
(in Rs. crores)

1

M/s Siemens Healthcare Private Limited

CT Scan and MRI

91.91

2

M/s Allengers Medical Systems Limited (AMSL)

CT Scan, MRI, Ultrasonography, X-Ray, Cath Lab, Positron Emission Tomography (PET) Systems, Single Photon Emission Tomography (SPECT), Mammography and C arm.

50.00

3

M/s Allengers OEM Private Limited (AOPL)

X Ray Tubes, Collimators, Flat Panel Detector and Monitors'

40.00

4

M/s Wipro GE Healthcare Private Limited (WGHPL)

‘CT Scan', ‘Cath Lab' and ‘Ultrasonography'

50.22

5

M/s Nipro India Corporatio Private Limited (NICPL)

‘Dialyzer'

180.00

6

M/s Wipro GE Healthcare Private Limited (WGHPL)

‘Anaesthesia Unit Ventilator' and ‘Patient Monitor'

53.86

7

M/s Sahajanand Medical Technologies Private Limited (SMTPL)

‘Heart Valves', ‘Stents', ‘PTCA Balloon Dilatation Catheter' and ‘Heart Occluders'

166.89

8

M/s Innvolution Healthcare Private Limited (IHPL)

‘Stents' and ‘PTCA Balloon Dilation Catheter'

21.75

9

M/s Integris Health Private Limited (IHPL) for Eligible Products

Transcatheter Aortic Heart Valve

75.00

The setting up of these plants will lead to a total committed investment of Rs. 729.63 crore by the companies and employment generation of about 2,304. The commercial production is projected to commence from 1 st April, 2022 and the disbursal of production linked incentive by the Government over the five years period would be up to a maximum of Rs.121.00 crore per applicant per target segment. The setting of these plants will make the country self-reliant to a large extent in the specified target segments in the Medical Devices Sector. The remaining pending applications are proposed to be taken up for approval by end of February, 2021.

 


POST YOUR COMMENTS
   

AR not Afar by SK Rahman

TIOL Tube Latest

Shri Shailendra Kumar, Trustee, TIOL Trust, giving welcome speech at TIOL Awards 2023




Shri M C Joshi, Former Chairman, CBDT




Address by Shri Buggana Rajendranath, Hon'ble Finance Minister of Andhra Pradesh at TIOL Awards 2023